Larimar Therapeutics is deeply undervalued, trading at ~$3.40 despite a de-risked safety profile and a clear regulatory path ...
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer acetate (Copaxone, Glatopa), the agency announced on Wednesday. The warning ...
NHSBSA prescription data drives clinical research to enhance anaphylaxis management and patient safety14 January 2026Two new research papers show how NHS Business Services Authority (NHSBSA) ...
Penicillin is the most common cause of drug-induced anaphylaxis. The incidence of allergy to penicillin is around 1 in 500 of the population. Many of these individuals may escape with just a skin rash ...
Dr. F. Dan Atkins answers the question: 'Lab Tests For Anaphylaxis?' — -- Question: Are there lab tests that can be done to determine if a reaction was due to anaphylaxis? Answer: The diagnosis ...
Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments. The treatment, called Neffy, was ...
New guidelines help non-medics correctly identify acute allergic reactions requiring epinephrine administration ...
New research based on real-world data largely aligns with the scientific literature, although one monoclonal antibody—dupilumab—stood out for its very low risk. Patients receiving monoclonal ...
Please provide your email address to receive an email when new articles are posted on . Anaphylaxis is often underdiagnosed and undertreated in children, but researchers at a busy tertiary care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback